FN2 Earnings Intelligence

TG Therapeutics, Inc. income statement

TG Therapeutics, Inc. (TGTX) Income Statement (annual) derived from persisted SEC financial facts.

Income Statement

USD in millions, except per-share values and percentages.

Metric 12/31/202112/31/202212/31/202312/31/202412/31/202512/31/2026 est.12/31/2027 est.
Revenue $6.7$2.8$233.7$329$616.3$993.7$1,344.3
Gross Profit --$219.5$290.5$515.6--
EBITDA -$344.5-$192.5$20.8$42$123.4--
Net Income -$348.1-$198.3$12.7$23.4$447.2--
Diluted EPS --$1.46$0.09$0.15$2.77$1.03$2.77

Get the TGTX recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.